A 6-week, randomized, double-blind, placebo-controlled study of the efficacy and safety of risperidone in adolescents with schizophrenia (Q43207474)

From Wikidata
Jump to navigation Jump to search
scientific article published in December 2009
edit
Language Label Description Also known as
English
A 6-week, randomized, double-blind, placebo-controlled study of the efficacy and safety of risperidone in adolescents with schizophrenia
scientific article published in December 2009

    Statements

    A 6-week, randomized, double-blind, placebo-controlled study of the efficacy and safety of risperidone in adolescents with schizophrenia (English)
    Magali Haas
    Alan S Unis
    Jorge Armenteros
    Margaret D Copenhaver
    Jorge A Quiroz
    Stuart F Kushner
    1 December 2009
    611-621

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit